Deloitte CFO Survey Q3 2026: Economic and political uncertainty seen as the greatest constraint on UK competitiveness
Geopolitics now tops the CFO risk list for more than three years; CFOs expect inflation and interest rate rises as the cost of credit hits a two-and-a-half year high;Cost reduction remains CFOs' top business priority, with expansionary strategies losing favour;
British workers spend nearly £1bn of their own money on GenAI for work, landmark Deloitte research finds
The UK's largest survey of workplace AI adoption, based on responses from 25,000 workers, finds employees are spending an estimated £958 million annually on GenAI tools they use for work;Two-thirds of British workers have used GenAI tools for work;
Deloitte CFO Survey Q2 2026: Growing AI optimism
73% of CFOs are optimistic that AI will materially improve business performance; 93% expect investment in digital technology to rise over the next 12 months; Geopolitics remains the biggest external risk to businesses; Cost control is biggest dampener to graduate hiring.
Deloitte digital consumer trends: over a third of consumers believe GenAI health advice is always accurate
A quarter of GenAI users have used the tool for advice about health or personal problemsHuman interaction in customer service is still the preference for consumers Four in five (81%) UK consumers don’t want AI to replace actors in film and TVA quarter (26%
Deloitte strengthens Cambridgeshire leadership with partner promotions
Deloitte has boosted its senior ranks in Cambridge with two new partner appointments, part of the firm’s annual promotions round-up.
Deloitte launches 'Adopt 100' programme with NVIDIA to accelerate AI adoption for businesses
Deloitte announces the launch of 'Adopt 100' with NVIDIA - a new programme designed to help businesses unlock the full potential of AI. Launched at an exclusive event during London Tech Week, Adopt 100 will integrate NVIDIA-accelerated AI solutions from leading startups into Deloitte's solutions for clients.
Weight loss drugs boom drives pharma R&D returns, but industry could face ‘bubble’ effect
Top global pharma companies’ return on R&D increased for third consecutive year; Growth is almost entirely driven by GLP-1 drugs - used to treat obesity and diabetes - and accounts for 38% of projected sales;Obesity drugs have displaced oncology dr
Deloitte invites rapidly growing tech scale-ups across Cambridgeshire and the East of England to apply for prestigious Technology Fast 50
Deloitte is calling on the most innovative and rapidly growing technology scale-ups across Cambridgeshire and the East of England to apply for the firm’s prestigious UK Technology Fast 50. Applications for this year's programme are officially open.
UK CFOs upbeat on tech investment and potential for AI to boost productivity for year ahead
More than half of finance chiefs (59%) have become more optimistic over the past 12 months on the potential for AI to boost the performance of their organisation, up from 39% in Q3 of 2024; Almost all of them (96%) expect to see a rise in investment in digital technology and assets by UK companies in the next five years; Corporate risk appetite (15%) has edged up from the lows seen in…
UK health: Focus on prevention can deliver £8 for each £1 invested
UK has the potential to unlock £8 in socio-economic returns for every £1 spent on preventive healthcare, according to new Deloitte analysis; Increasing prevention spend from current 6% to 10% could lead to £42 billion of savings to the UK healthcare system in 10 years; A 7% reduction in preventable deaths could save over 5,400 lives annually, with a societal value of £6 billion.
Journee tops Deloitte UK Technology Fast 50 ranking with Cambridgeshire companies Levidian, Monavate and Obrizum in top ranking
Travel company Journee has topped Deloitte’s 2025 UK Technology Fast 50 awards, a ranking of the UK’s 50 fastest-growing technology companies;The London-based company reported a three-year growth rate of 10,171% to the year 2024/25;The combined revenue
Deloitte welcomes next generation of talent with nearly 1,500 graduate and apprentice hires
New graduates, apprentices, and industrial placements join Deloitte New starters joined across 17 Deloitte locations in the UK; with 32 new joiners in Cambridge. Induction covered Deloitte’s values, sustainability goals, and the firm’s GenAI platform.
Deloitte CFO Survey: UK rises up the list of attractiveness for investment
Deloitte’s latest survey of UK Chief Financial Officers shows that finance leaders see the UK as the most attractive destination when it comes to investment, alongside India, with a net1 13% describing it as very or somewhat attractive.
One year anniversary of the Deloitte Cambridge ‘super hub’ supporting nearly 300 local start-ups
Dozens of pharmaceutical companies and tech start-ups came together on Wednesday (14 May), to celebrate the one-year anniversary of a ‘super hub’ they have used to help accelerate their business. The Deloitte Life Sciences Catalyst business lounge in Cambridge has helped hundreds of local and regional start-ups across the life sciences industry access a boardroom meeting space and…
Deloitte 2025 Technology Fast 50: The fastest growing tech companies in the UK Applications now open!
We’re delighted to announce that nominations for the 2025 UK Technology Fast 50 awards are now open! Apply today and you could join the likes of Deliveroo, Revolut and Skyscanner as a UK Technology Fast 50 winner. Application deadline: Midnight, Friday 27 June 2025
Global pharma R&D returns rise as GLP-1 drugs help drive forecast growth
The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs helping to boost growth, according to analysis by Deloitte.
UK drivers among most sceptical globally about AI in cars
Over a quarter of UK drivers do not trust AI in cars, mirroring skepticism in the US (26%) and Germany (25%); This contrasts with high acceptance rates of AI in cars in India (82%) and China (77%); Consumer concerns centre around data privacy and the ability of autonomous vehicles to navigate real-time driving scenarios; Deloitte study also finds UK drivers rank highest globally for preferring to…
Deloitte Cambridge and Castle Manor Academy in Haverhill announce new partnership
Deloitte Cambridge and Castle Manor Academy in Haverhill are delighted to announce a new partnership, part of the firm’s 5 Million Futures programme.
Cambridgeshire and East Anglia companies in Deloitte UK Tech Fast 50 ranking
In a ranking of the UK’s 50 fastest growing technology companies, Halo Service Solutions and bit.bio secure places For a second year running, online blanking platform Allica Bank has topped the UK ranking;
UK CFOs gear up for growth following the election
Corporate risk appetite among UK CFOs has seen its biggest rise in more than four years, following the general election;
Deloitte’s Annual Review of Football Finance: European football market revenues rise by 16% to €35.3 billion in 2022/23 season
The European football market grew by 16% in the 2022/23 season to €35.3bn, boosted by the lifting of all remaining COVID-19 restrictions and the 2022 FIFA World Cup; The ‘big five’ European leagues generated total revenue of €19.6bn, up €2.3bn (14%) on the previous season, and reported an aggregate operating profit (€0.5bn) for the first time since 2018/19; Premier League clubs’ revenue…
Deloitte Cambridge opens new business lounge
The Life Sciences Catalyst Business Lounge, designed to be a regional hotspot for start-ups and world-leading businesses in the life sciences sector, has been opened by Deloitte Cambridge.
Deloitte Cambridge appoints new office senior partner
Deloitte has appointed Julian Rae as the new office senior partner for Deloitte Cambridge following Paul Schofield’s decision to step down after 10 years at the helm.
Deloitte’s UK Technology Fast 50 Awards open for nominations now
27th edition of the awards recognises the fastest growing technology companies in the UK, entry now open.
Global pharma companies’ return on R&D investment increases after record low
Projected return on innovation in pharma R&D in 2023 has risen to 4.1 per cent, indicating a potential recovery from the long term downward trend in R&D productivity; The top 20 global pharmaceutical companies spent $145 billion on R&D investments in 2022-23*; AI is yet to become a ‘game-changer’ in pharma R&D.